| Typicality: | 0.542 |
| Saliency: | 0.305 |
| trial → be funded by → pfizer | 8 |
| trial → be sponsored by → pfizer | 8 |
| trial → be supported by → pfizer | 4 |
| negative | neutral | positive |
| 0.114 | 0.724 | 0.162 |
| Raw frequency | 20 |
| Normalized frequency | 0.305 |
| Modifier score | 1.000 |
| Perplexity | 62.860 |